TipRanks
Go Ultimate55% OFF

Alcon (ALCN) Stock Price & Analysis

ALCN Stock Chart & Stats

MX$1,228.68MX$0.00(0.00%)
At close:
Mex$1.15KMex$1.2KMex$1.25KMex$1.3K22 Apr5 Jun21 Jul
Day’s Range
MXN 1,228.68 - MXN 1,228.68
52-Week Range
MXN 1,158.00 - MXN 1,492.31
Previous Close
MXN 1,228.68
Volume
0
Average Volume (3M)
0
Market Cap
MXN 672.44B
Enterprise Value
MXN 29.78B
Total Cash (Recent Filing)
MXN 1.46B
Total Debt (Recent Filing)
MXN 5.31B
Price to Earnings (P/E)
55.0
Beta
0.00
Next Earnings
Nov 10, 2026 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
0.60%

Bulls Say, Bears Say

Bulls Say

Durable Revenue Growth

Multi-year revenue expansion indicates durable demand across Alcon’s eye-care portfolio rather than reliance on a single product or period. Continued growth across franchises and geographies can support operating scale, strengthen customer relationships, and provide a foundation for sustained earnings development.

Broad Product Momentum And Market Position

Market-share gains in contact lenses and rapid adoption of newer products show that Alcon is converting innovation into commercial traction. A broad portfolio spanning surgical, contact-lens, and ocular-health categories can reinforce its competitive position and support recurring customer demand.

Strong Cash Generation And Conservative Leverage

Improving free cash flow and conservative leverage give Alcon financial flexibility to fund product development, commercialization, and shareholder returns without relying heavily on additional borrowing. This supports resilience through investment cycles while preserving capacity for strategic capital allocation.

Bears Say

Recent Profitability And Return Compression

The recent decline in net margin and ROE shows that revenue growth has not fully translated into stronger returns. If operating costs or pricing pressure persist, profitability may remain below prior levels, limiting earnings conversion and reducing the benefit of otherwise healthy gross margins.

PowerVision Program Discontinuation

Ending the PowerVision programs removes a potential long-term accommodating-IOL growth pathway and represents an R&D setback. It may also redirect development resources and leave Alcon with fewer future product options in an area where differentiated innovation could have strengthened its surgical portfolio.

Competitive And Adoption Pressure In Surgical Products

Slower implantables growth and limited Hydrus adoption indicate that competitive launches, reimbursement changes, and customer uptake are constraining parts of Surgical. Persistent pressure in these categories could weaken portfolio growth and make future expansion more dependent on newer launches.

Alcon News

ALCN FAQ

What was Alcon’s price range in the past 12 months?
Alcon lowest stock price was Mex$1158.00 and its highest was Mex$1492.31 in the past 12 months.
What is Alcon’s market cap?
Alcon’s market cap is Mex$672.44B.
When is Alcon’s upcoming earnings report date?
Alcon’s next earnings report is estimated for Nov 10, 2026 (not yet confirmed), which is in 7 days.
How were Alcon’s earnings last quarter?
Alcon released its earnings results on Aug 10, 2026. The company reported Mex$15.506 earnings per share for the quarter, beating the consensus estimate of Mex$13.753 by Mex$1.753.
Is Alcon overvalued?
According to Wall Street analysts Alcon’s price is currently Undervalued.
Does Alcon pay dividends?
Alcon does not currently pay dividends.
What is Alcon’s EPS estimate?
Alcon’s EPS estimate is 16.35.
How many shares outstanding does Alcon have?
Alcon has 499,700,000 shares outstanding.
What happened to Alcon’s price movement after its last earnings report?
Alcon reported an EPS of Mex$15.506 in its last earnings report, beating expectations of Mex$13.753. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Alcon?
Hedge funds hold Alcon shares: hedge funds decreased their holdings by 352.4K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology